Rosetta Inks Agreement with Three Rivers to Offer Access to Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has signed a credentialing agreement with Three Rivers Provider Network, which will offer the firm's Cancer Origin Test to members of the preferred provider organization.

Three Rivers, based in Chula Vista, Calif., provides health benefits to more than 10 million members nationwide. It also has more than 600,000 providers, 5,000 hospitals, and 70,000 ancillary facilities in its network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.